Sort
16,300 grants matching “fatty liver disease”
Mitofunction, Microarray and Screening for She inhibitors
$250,872Gino A Cortopassi · University Of California At Davis · P01 · FY2017 · AG
Potential Mechanisms of Glucagon-like peptide-1 in Fatty Liver Disease
$250,865Frank A. Anania · Emory University · R01 · FY2010 · DK
Calorie restriction and aging
$250,843Rafael De Cabo · National Institute On Aging · ZIA · FY2012 · AG
Cholestasis Reversal (Phase ll): Efficacy of lV Fish Oil
$250,757Mark Puder · Boston Children'S Hospital · R01 · FY2008 · FD
Improving omega-3 fatty acid supplementation with microencapsulation
$250,752Alfred L Fisher · University Of Texas Hlth Science Center · R21 · FY2019 · NS
Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks
$250,508Christina Chan · Michigan State University · R01 · FY2008 · GM
Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks
$250,508Christina Chan · Michigan State University · R01 · FY2009 · GM
Animal Phenotyping (Core B)
$250,505Gary J Schwartz · Columbia University Health Sciences · P30 · FY2016 · DK
Role of Lipoproteins in Chagasic heart disease
$250,500Jyothi Falguni Nagajyothi · Albert Einstein College Of Medicine · R21 · FY2012 · HL
Understanding the molecular regulation of autophagy during aging
$250,500Rajat Singh · Albert Einstein College Of Medicine, Inc · R21 · FY2017 · AG
Role of ABCA1 in neurodegeneration
$250,496Radosveta P Koldamova · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · AG
The role of long chain acyl-CoAs in nuclear receptor regulation
$250,453Heather A Hostetler · Wright State University · R00 · FY2009 · DK
The role of oxysterols in placental biology
$250,447Jacob C Larkin · Magee-Women'S Res Inst And Foundation · R21 · FY2016 · HD
Clinical utility of leptin therapy in syndromic forms of insulin resistance.
$250,260Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Influence of Obesity on Endogenous Oxalate Synthesis
$250,242Ross P Holmes · University Of Alabama At Birmingham · P20 · FY2020 · DK
Regional Metabolomics and Fluxomics Core at Princeton
$250,095Joshua D Rabinowitz · University Of Pennsylvania · P30 · FY2024 · DK
Regional Metabolomics and Fluxomics Core at Princeton
$250,095Joshua D Rabinowitz · University Of Pennsylvania · P30 · FY2023 · DK
Molecular mechanisms of fatty liver disease: role of the protein DBC1
$250,093Eduardo N Chini · Mayo Clinic Rochester · R01 · FY2013 · DK
CD36 AND INTESTINAL FAT ABSORPTION
$250,057Nada A. Abumrad · Washington University · R01 · FY2013 · DK
Regional Metabolomics and Fluxomics Core at Princeton
$250,012Joshua D Rabinowitz · University Of Pennsylvania · P30 · FY2025 · DK
A novel agent for preventing fatty degeneration of muscles in LGMD2B
$250,011Monique Floer · Advertent Biotherapeutics, Inc. · R43 · FY2022 · AR
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
$250,001Ayako Suzuki · Duke University · U01 · FY2024 · DK
The Saint Louis University Component of the NASH Clinical Research Network
$250,001Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2024 · DK
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
$250,001Arun J Sanyal · Virginia Commonwealth University · U01 · FY2025 · DK
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
$250,001Anna Mae Elizabeth Diehl · Duke University · U01 · FY2025 · DK